Drug Database
Back to search

Poland· PL-100002243

Acenocumarol WZF

A acenocoumarol product containing acenocoumarolum, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 7 of our 19 countries.

ATC B01AA07

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAcenocumarol WZFATCB01AA07REGISTER NO.PL-100002243PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about acenocoumarolumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Acenocoumarol is registered in 7 of 19 countries.

Countries holding a registration under ATC B01AA07 (acenocoumarol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose
Search acenocoumarol products by name

Acenocoumarol · ATC B01AA07

7 / 19 countries

  • Belgiumprice
  • Franceprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acenocoumarol costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.21 in France to $0.50 in Switzerland — a ×2.4 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Acenocoumarol · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.50
  • FR France$0.21
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Acenocoumarolum
Manufacturer
Zakłady Farmaceutyczne POLPHARMA S.A.
Country
Poland (PL)
ATC code
B01AA07
ATC class
Acenocoumarol
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • gtin
    05909990055715
    60 szt.
    PLN 14.66

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

209 interactions on record for acenocoumarol.

Graded by severity as the source publishes them — 142 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check acenocoumarol against other medicinesHow interaction checks work

Acenocoumarol · interactions on record

209 records

  • 142 info

Most severe, free to view

    67 more interactions with mechanism and management, from a commercially licensed source.

    Sign in to check
    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Acenocoumarol in 6 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All acenocoumarol products

    Authorised across Europe · EMA

    The same active substance is authorised in 13 EEA countries. Names it is sold under:

    • Austria · Sintrom
    • Belgium · Sintrom
    • Bulgaria · Синтром
    • Spain · Acenocumarol Aurovitas, Sintrom
    • France · Mini-Sintrom, Sintrom
    • United Kingdom (Northern Ireland) · Sinthrome
    • Greece · Sintrom
    • Hungary · Syncumar Mite
    • Italy · Sintrom
    • Luxembourg · Sintrom
    • Netherlands · Acenocoumarol Aurobindo, Acenocoumarol Cf
    • Portugal · Acenocumarol Generis, Sintrom
    • Romania · Sintrom, Trombostop

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/b7c29a0d-fa23-49ac-84b3-78054714263b
GET /v1/drugs/b7c29a0d-fa23-49ac-84b3-78054714263b?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Tabletki",
  "source": "urpl",
  "strength": "4 mg",
  "packaging": "05909990055715 ¦ Rp ¦ 393\n60 tabl.",
  "substance": "Acenocoumarolum 4 mg",
  "common_name": "Acenocoumarolum",
  "pl_product_id": "100002243",
  "pozwolenie_nr": "00557",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
    API referenceMCP serverPlans

    See everything about acenocoumarol.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console